Literature DB >> 31529285

A Myriad of Scleroma Presentations: The Usual and Unusual.

Samy Elwany1, Hesham Abdel Fattah2, Zeyad Mandour2, Ahmed Soliman Ismail2, Mostafa Abdelnabi2.   

Abstract

To prospectively study a series of scleroma patients with a focus on socioeconomic status, clinical presentation, pathology, microbiology, and treatment. A total of 52 patients diagnosed with scleroma were included in the study. Demographic data of the patients were collected and clinical, radiographic, and histopathologic findings were analyzed. Biopsies from atypical patients were sent for electron microscopic examination. Patients were treated both medically and surgically with clinical follow-up to determine outcomes and the incidence of recurrence. Fifty-two patients were included in the study. There were 23 males (44.2%) and 29 females (55.8%). The highest incidence of scleroma was identified in individuals from poor, rural areas in the third to fourth decades of life. The nose was affected in all cases. Other affected sites included the nasopharynx, soft and hard palate, larynx and trachea, lacrimal passages, skin, and gingiva. Some patients had atypical presentations. Complete follow-up of all patients was hindered by non-compliance with clinic visits and the long duration of medical treatment. Recurrence or relapse of the granulomatous lesions after initial improvement occurred in 11 patients (21.2%) within 1 to 3 years. Scleroma is a stubborn, chronic, granulomatous bacterial disease. The diverse presentations may mimic neoplasms and other granulomatous conditions. We present cases with unusual presentations and demonstrate the transmission electron microscopic features of these lesions. Furthermore, we confirm the importance of achieving full eradication of the etiologic bacilli to prevent recurrent disease.

Entities:  

Keywords:  Granuloma; Klebsiella; Nose; Rhinoscleroma; Tracheostomy

Mesh:

Year:  2019        PMID: 31529285      PMCID: PMC7413941          DOI: 10.1007/s12105-019-01075-5

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  11 in total

1.  THE UVULA SIGN IN SCLEROMA OF THE NASOPHARYNX.

Authors:  R BADRAWY
Journal:  Ann Otol Rhinol Laryngol       Date:  1965-06       Impact factor: 1.547

2.  Affection of cervical lymph nodes in rhinoscleroma.

Authors:  R Badrawy; M el-Shennawy
Journal:  J Laryngol Otol       Date:  1974-03       Impact factor: 1.469

3.  Malignant changes in scleroma.

Authors:  A P Singh; R N Srivastava
Journal:  Laryngoscope       Date:  1972-03       Impact factor: 3.325

4.  Scleroma of the antrum and ethmoid.

Authors:  P Chatterji; S M Verma; J S Mathur
Journal:  J Laryngol Otol       Date:  1969-09       Impact factor: 1.469

5.  Klebsiella rhinoscleromatis: a clinical and pathogenic enigma.

Authors:  R H Miller; J B Shulman; R F Canalis; P H Ward
Journal:  Otolaryngol Head Neck Surg (1979)       Date:  1979 Mar-Apr

6.  Respiratory scleroma: a clinicopathologic and ultrastructural study.

Authors:  H O Sedano; R Carlos; I G Koutlas
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1996-06

7.  Scleroma of the trachea associated with Pseudomonas pyocyanea.

Authors:  K J Murphy
Journal:  Thorax       Date:  1966-07       Impact factor: 9.139

8.  Scleroma of the lower respiratory tract: a bronchoscopic study.

Authors:  N K Soni
Journal:  J Laryngol Otol       Date:  1994-06       Impact factor: 1.469

Review 9.  Rhinoscleroma.

Authors:  Brandon Umphress; Kirtee Raparia
Journal:  Arch Pathol Lab Med       Date:  2018-08-31       Impact factor: 5.534

10.  Rhinoscleroma treated with ciprofloxacin: a case report.

Authors:  R K Avery; S D Salman; A S Baker
Journal:  Laryngoscope       Date:  1995-08       Impact factor: 3.325

View more
  1 in total

1.  Central airway obstruction: is it time to move forward?

Authors:  Fernando Guedes; Mariana V Branquinho; Ana C Sousa; Rui D Alvites; António Bugalho; Ana Colette Maurício
Journal:  BMC Pulm Med       Date:  2022-02-19       Impact factor: 3.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.